Miyo M, Kato T, Yoshino T, Yamanaka T, et al. Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer. BMC Cancer 2020;20:687.
PMID: 32703200